nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP3A4—bone cancer	0.706	1	CbGaD
Ropivacaine—Lidocaine—EGFR—bone cancer	0.00243	0.294	CrCbGaD
Ropivacaine—Levobupivacaine—CYP3A4—bone cancer	0.00189	0.229	CrCbGaD
Ropivacaine—Ranolazine—CYP3A4—bone cancer	0.00154	0.187	CrCbGaD
Ropivacaine—Bupivacaine—CYP3A4—bone cancer	0.00151	0.183	CrCbGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—T—bone cancer	0.000985	0.0804	CbGpPWpGaD
Ropivacaine—Lidocaine—CYP3A4—bone cancer	0.000886	0.107	CrCbGaD
Ropivacaine—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.000832	0.0679	CbGpPWpGaD
Ropivacaine—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000515	0.00188	CcSEcCtD
Ropivacaine—Hepatic function abnormal—Doxorubicin—bone cancer	0.000512	0.00187	CcSEcCtD
Ropivacaine—Malaise—Cisplatin—bone cancer	0.000512	0.00187	CcSEcCtD
Ropivacaine—Purpura—Epirubicin—bone cancer	0.000502	0.00183	CcSEcCtD
Ropivacaine—Vascular purpura—Doxorubicin—bone cancer	0.0005	0.00183	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Epirubicin—bone cancer	0.0005	0.00182	CcSEcCtD
Ropivacaine—Hypoglycaemia—Epirubicin—bone cancer	0.000496	0.00181	CcSEcCtD
Ropivacaine—Convulsion—Cisplatin—bone cancer	0.000492	0.00179	CcSEcCtD
Ropivacaine—Mood swings—Methotrexate—bone cancer	0.00049	0.00179	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—FEV—bone cancer	0.000489	0.0399	CbGpPWpGaD
Ropivacaine—Osteoarthritis—Epirubicin—bone cancer	0.000484	0.00177	CcSEcCtD
Ropivacaine—Myalgia—Cisplatin—bone cancer	0.000483	0.00176	CcSEcCtD
Ropivacaine—Anxiety—Cisplatin—bone cancer	0.000481	0.00176	CcSEcCtD
Ropivacaine—Discomfort—Cisplatin—bone cancer	0.000477	0.00174	CcSEcCtD
Ropivacaine—Affect lability—Epirubicin—bone cancer	0.000476	0.00174	CcSEcCtD
Ropivacaine—Breast disorder—Methotrexate—bone cancer	0.000467	0.00171	CcSEcCtD
Ropivacaine—Purpura—Doxorubicin—bone cancer	0.000465	0.0017	CcSEcCtD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000464	0.0379	CbGpPWpGaD
Ropivacaine—Anaphylactic shock—Cisplatin—bone cancer	0.000463	0.00169	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000463	0.00169	CcSEcCtD
Ropivacaine—Cardiac arrest—Epirubicin—bone cancer	0.00046	0.00168	CcSEcCtD
Ropivacaine—Infection—Cisplatin—bone cancer	0.00046	0.00168	CcSEcCtD
Ropivacaine—Hypoglycaemia—Doxorubicin—bone cancer	0.000459	0.00167	CcSEcCtD
Ropivacaine—Mood swings—Epirubicin—bone cancer	0.000458	0.00167	CcSEcCtD
Ropivacaine—Thrombocytopenia—Cisplatin—bone cancer	0.000453	0.00166	CcSEcCtD
Ropivacaine—Tachycardia—Cisplatin—bone cancer	0.000452	0.00165	CcSEcCtD
Ropivacaine—Skin disorder—Cisplatin—bone cancer	0.00045	0.00164	CcSEcCtD
Ropivacaine—Osteoarthritis—Doxorubicin—bone cancer	0.000448	0.00163	CcSEcCtD
Ropivacaine—Hyperhidrosis—Cisplatin—bone cancer	0.000448	0.00163	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—bone cancer	0.000442	0.00161	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—bone cancer	0.000441	0.00161	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—bone cancer	0.00044	0.00161	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—bone cancer	0.000437	0.0016	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000436	0.00159	CcSEcCtD
Ropivacaine—Hypotension—Cisplatin—bone cancer	0.000433	0.00158	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000427	0.00156	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—bone cancer	0.000426	0.00155	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—bone cancer	0.000424	0.00155	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000422	0.00154	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—bone cancer	0.000421	0.00154	CcSEcCtD
Ropivacaine—Dysuria—Methotrexate—bone cancer	0.000418	0.00153	CcSEcCtD
Ropivacaine—Paraesthesia—Cisplatin—bone cancer	0.000416	0.00152	CcSEcCtD
Ropivacaine—Dyspnoea—Cisplatin—bone cancer	0.000413	0.00151	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000409	0.00149	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—bone cancer	0.000407	0.00149	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—bone cancer	0.000405	0.00148	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000403	0.00147	CcSEcCtD
Ropivacaine—Drowsiness—Methotrexate—bone cancer	0.000398	0.00145	CcSEcCtD
Ropivacaine—Depression—Methotrexate—bone cancer	0.000397	0.00145	CcSEcCtD
Ropivacaine—Pain—Cisplatin—bone cancer	0.000396	0.00145	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000395	0.00144	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—bone cancer	0.000391	0.00143	CcSEcCtD
Ropivacaine—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00039	0.0318	CbGpPWpGaD
Ropivacaine—Abdominal distension—Doxorubicin—bone cancer	0.00039	0.00142	CcSEcCtD
Ropivacaine—Feeling abnormal—Cisplatin—bone cancer	0.000382	0.00139	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—bone cancer	0.00038	0.00139	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—bone cancer	0.000377	0.00138	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—bone cancer	0.000373	0.00136	CcSEcCtD
Ropivacaine—Body temperature increased—Cisplatin—bone cancer	0.000366	0.00134	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—bone cancer	0.000366	0.00133	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—bone cancer	0.000363	0.00133	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—bone cancer	0.000362	0.00132	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—bone cancer	0.000362	0.00132	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—bone cancer	0.000356	0.0013	CcSEcCtD
Ropivacaine—Urinary tract disorder—Methotrexate—bone cancer	0.000353	0.00129	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—bone cancer	0.000351	0.00128	CcSEcCtD
Ropivacaine—Hyperglycaemia—Doxorubicin—bone cancer	0.000349	0.00127	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—bone cancer	0.000345	0.00126	CcSEcCtD
Ropivacaine—Hypersensitivity—Cisplatin—bone cancer	0.000341	0.00125	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—bone cancer	0.000341	0.00124	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000338	0.00123	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—bone cancer	0.000336	0.00123	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—bone cancer	0.000336	0.00122	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—bone cancer	0.000335	0.00122	CcSEcCtD
Ropivacaine—Tinnitus—Methotrexate—bone cancer	0.000334	0.00122	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—bone cancer	0.000333	0.00122	CcSEcCtD
Ropivacaine—Asthenia—Cisplatin—bone cancer	0.000332	0.00121	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—bone cancer	0.000332	0.00121	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—bone cancer	0.000331	0.00121	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—bone cancer	0.00033	0.0012	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—bone cancer	0.000329	0.0012	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—bone cancer	0.000328	0.0012	CcSEcCtD
Ropivacaine—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000324	0.0264	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000322	0.0263	CbGpPWpGaD
Ropivacaine—Chills—Methotrexate—bone cancer	0.000321	0.00117	CcSEcCtD
Ropivacaine—Diarrhoea—Cisplatin—bone cancer	0.000317	0.00116	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—bone cancer	0.000315	0.00115	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—bone cancer	0.000313	0.00114	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—bone cancer	0.000312	0.00114	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—bone cancer	0.000311	0.00114	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—bone cancer	0.000311	0.00113	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—bone cancer	0.000311	0.00113	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—bone cancer	0.000308	0.00112	CcSEcCtD
Ropivacaine—Urinary tract disorder—Doxorubicin—bone cancer	0.000306	0.00112	CcSEcCtD
Ropivacaine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000305	0.0249	CbGpPWpGaD
Ropivacaine—Oedema peripheral—Doxorubicin—bone cancer	0.000305	0.00111	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—bone cancer	0.000304	0.00111	CcSEcCtD
Ropivacaine—Back pain—Methotrexate—bone cancer	0.000301	0.0011	CcSEcCtD
Ropivacaine—Chills—Epirubicin—bone cancer	0.0003	0.0011	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—bone cancer	0.000299	0.00109	CcSEcCtD
Ropivacaine—Vomiting—Cisplatin—bone cancer	0.000294	0.00107	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—bone cancer	0.000293	0.00107	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—bone cancer	0.000293	0.00107	CcSEcCtD
Ropivacaine—Rash—Cisplatin—bone cancer	0.000292	0.00107	CcSEcCtD
Ropivacaine—Dermatitis—Cisplatin—bone cancer	0.000292	0.00106	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—bone cancer	0.000291	0.00106	CcSEcCtD
Ropivacaine—Ill-defined disorder—Methotrexate—bone cancer	0.000289	0.00105	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—bone cancer	0.000289	0.00105	CcSEcCtD
Ropivacaine—Anaemia—Methotrexate—bone cancer	0.000288	0.00105	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—bone cancer	0.000287	0.00105	CcSEcCtD
Ropivacaine—Tension—Epirubicin—bone cancer	0.000286	0.00104	CcSEcCtD
Ropivacaine—Nervousness—Epirubicin—bone cancer	0.000283	0.00103	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—bone cancer	0.000282	0.00103	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—bone cancer	0.000281	0.00102	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—bone cancer	0.00028	0.00102	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—bone cancer	0.00028	0.00102	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—bone cancer	0.000278	0.00101	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—bone cancer	0.000277	0.00101	CcSEcCtD
Ropivacaine—Nausea—Cisplatin—bone cancer	0.000275	0.001	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—bone cancer	0.000275	0.001	CcSEcCtD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000273	0.0223	CbGpPWpGaD
Ropivacaine—Cough—Methotrexate—bone cancer	0.000272	0.000992	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—bone cancer	0.000271	0.000991	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—bone cancer	0.00027	0.000987	CcSEcCtD
Ropivacaine—Convulsion—Methotrexate—bone cancer	0.00027	0.000985	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—bone cancer	0.00027	0.000984	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—bone cancer	0.000269	0.000983	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—bone cancer	0.000268	0.000977	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—bone cancer	0.000265	0.000968	CcSEcCtD
Ropivacaine—Myalgia—Methotrexate—bone cancer	0.000265	0.000968	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—bone cancer	0.000265	0.000968	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—bone cancer	0.000265	0.000966	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—bone cancer	0.000263	0.000959	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—bone cancer	0.000262	0.000956	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—bone cancer	0.000262	0.000956	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—bone cancer	0.000262	0.000956	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—bone cancer	0.000261	0.000954	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—bone cancer	0.000261	0.000952	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—bone cancer	0.000259	0.000946	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—bone cancer	0.000256	0.000935	CcSEcCtD
Ropivacaine—Loss of consciousness—Epirubicin—bone cancer	0.000256	0.000935	CcSEcCtD
Ropivacaine—Cough—Epirubicin—bone cancer	0.000254	0.000928	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—bone cancer	0.000254	0.000928	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—bone cancer	0.000254	0.000928	CcSEcCtD
Ropivacaine—Convulsion—Epirubicin—bone cancer	0.000252	0.000922	CcSEcCtD
Ropivacaine—Infection—Methotrexate—bone cancer	0.000252	0.000922	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—bone cancer	0.000252	0.000918	CcSEcCtD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000251	0.0205	CbGpPWpGaD
Ropivacaine—Ill-defined disorder—Doxorubicin—bone cancer	0.00025	0.000913	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—bone cancer	0.000249	0.00091	CcSEcCtD
Ropivacaine—Thrombocytopenia—Methotrexate—bone cancer	0.000249	0.000908	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—bone cancer	0.000248	0.000906	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—bone cancer	0.000248	0.000906	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—bone cancer	0.000248	0.000906	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—bone cancer	0.000248	0.000904	CcSEcCtD
Ropivacaine—Anxiety—Epirubicin—bone cancer	0.000247	0.000902	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—bone cancer	0.000247	0.000901	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—bone cancer	0.000246	0.000897	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—bone cancer	0.000245	0.000895	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—bone cancer	0.000243	0.000888	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—bone cancer	0.000242	0.000884	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—bone cancer	0.000242	0.000883	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—bone cancer	0.00024	0.000875	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—bone cancer	0.000238	0.000868	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—bone cancer	0.000237	0.000867	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—bone cancer	0.000237	0.000865	CcSEcCtD
Ropivacaine—Infection—Epirubicin—bone cancer	0.000236	0.000862	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—bone cancer	0.000235	0.000859	CcSEcCtD
Ropivacaine—Shock—Epirubicin—bone cancer	0.000234	0.000854	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—bone cancer	0.000234	0.000853	CcSEcCtD
Ropivacaine—Thrombocytopenia—Epirubicin—bone cancer	0.000233	0.00085	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—bone cancer	0.000233	0.00085	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—bone cancer	0.000232	0.000847	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000232	0.000845	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—bone cancer	0.000231	0.000843	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—bone cancer	0.00023	0.000839	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—bone cancer	0.00023	0.000839	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—bone cancer	0.00023	0.000838	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—bone cancer	0.00023	0.000838	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—bone cancer	0.00023	0.000838	CcSEcCtD
Ropivacaine—Anxiety—Doxorubicin—bone cancer	0.000229	0.000835	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—bone cancer	0.000228	0.000833	CcSEcCtD
Ropivacaine—Discomfort—Doxorubicin—bone cancer	0.000227	0.000828	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—bone cancer	0.000227	0.000827	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—bone cancer	0.000226	0.000825	CcSEcCtD
Ropivacaine—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.000224	0.0183	CbGpPWpGaD
Ropivacaine—Dyspepsia—Methotrexate—bone cancer	0.000224	0.000817	CcSEcCtD
Ropivacaine—Hypotension—Epirubicin—bone cancer	0.000222	0.000811	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—bone cancer	0.000222	0.00081	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—bone cancer	0.00022	0.000803	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—bone cancer	0.000219	0.000798	CcSEcCtD
Ropivacaine—Pain—Methotrexate—bone cancer	0.000217	0.000793	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000217	0.000791	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—bone cancer	0.000216	0.00079	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—bone cancer	0.000215	0.000786	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—bone cancer	0.000215	0.000785	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—bone cancer	0.000215	0.000784	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—bone cancer	0.000214	0.00078	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—bone cancer	0.000214	0.00078	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—bone cancer	0.000213	0.000777	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—bone cancer	0.000212	0.000774	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—bone cancer	0.000211	0.000772	CcSEcCtD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000211	0.0172	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Methotrexate—bone cancer	0.000209	0.000764	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—bone cancer	0.000209	0.000764	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—bone cancer	0.000208	0.000759	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—bone cancer	0.000206	0.000751	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—bone cancer	0.000203	0.000742	CcSEcCtD
Ropivacaine—Pain—Epirubicin—bone cancer	0.000203	0.000742	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—bone cancer	0.000202	0.000737	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—bone cancer	0.000201	0.000733	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—bone cancer	0.000201	0.000733	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0002	0.000732	CcSEcCtD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.0002	0.0163	CbGpPWpGaD
Ropivacaine—Insomnia—Doxorubicin—bone cancer	0.000199	0.000726	CcSEcCtD
Ropivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000198	0.0162	CbGpPWpGaD
Ropivacaine—Paraesthesia—Doxorubicin—bone cancer	0.000198	0.000721	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—bone cancer	0.000196	0.000716	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—bone cancer	0.000196	0.000715	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—bone cancer	0.000196	0.000714	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—bone cancer	0.000194	0.00071	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—bone cancer	0.000194	0.000707	CcSEcCtD
Ropivacaine—Urticaria—Epirubicin—bone cancer	0.000189	0.00069	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—bone cancer	0.000188	0.000687	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—bone cancer	0.000188	0.000687	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—bone cancer	0.000188	0.000686	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—bone cancer	0.000188	0.000686	CcSEcCtD
Ropivacaine—Hypersensitivity—Methotrexate—bone cancer	0.000187	0.000683	CcSEcCtD
Ropivacaine—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000186	0.0152	CbGpPWpGaD
Ropivacaine—Asthenia—Methotrexate—bone cancer	0.000182	0.000666	CcSEcCtD
Ropivacaine—Feeling abnormal—Doxorubicin—bone cancer	0.000181	0.000662	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00018	0.000657	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—bone cancer	0.00018	0.000656	CcSEcCtD
Ropivacaine—Hypersensitivity—Epirubicin—bone cancer	0.000175	0.00064	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—bone cancer	0.000175	0.000638	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—bone cancer	0.000174	0.000635	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—bone cancer	0.000174	0.000635	CcSEcCtD
Ropivacaine—Diarrhoea—Methotrexate—bone cancer	0.000174	0.000635	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—bone cancer	0.000171	0.000623	CcSEcCtD
Ropivacaine—Pruritus—Epirubicin—bone cancer	0.000168	0.000614	CcSEcCtD
Ropivacaine—Dizziness—Methotrexate—bone cancer	0.000168	0.000613	CcSEcCtD
Ropivacaine—Diarrhoea—Epirubicin—bone cancer	0.000163	0.000594	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—bone cancer	0.000162	0.000592	CcSEcCtD
Ropivacaine—Vomiting—Methotrexate—bone cancer	0.000162	0.00059	CcSEcCtD
Ropivacaine—Rash—Methotrexate—bone cancer	0.00016	0.000585	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—bone cancer	0.00016	0.000584	CcSEcCtD
Ropivacaine—Headache—Methotrexate—bone cancer	0.000159	0.000581	CcSEcCtD
Ropivacaine—Asthenia—Doxorubicin—bone cancer	0.000158	0.000576	CcSEcCtD
Ropivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000158	0.0129	CbGpPWpGaD
Ropivacaine—Dizziness—Epirubicin—bone cancer	0.000157	0.000574	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—bone cancer	0.000156	0.000568	CcSEcCtD
Ropivacaine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000156	0.0127	CbGpPWpGaD
Ropivacaine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000154	0.0125	CbGpPWpGaD
Ropivacaine—Vomiting—Epirubicin—bone cancer	0.000151	0.000552	CcSEcCtD
Ropivacaine—Nausea—Methotrexate—bone cancer	0.000151	0.000551	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—bone cancer	0.000151	0.00055	CcSEcCtD
Ropivacaine—Rash—Epirubicin—bone cancer	0.00015	0.000547	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—bone cancer	0.00015	0.000547	CcSEcCtD
Ropivacaine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00015	0.0122	CbGpPWpGaD
Ropivacaine—Headache—Epirubicin—bone cancer	0.000149	0.000544	CcSEcCtD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000148	0.012	CbGpPWpGaD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000146	0.012	CbGpPWpGaD
Ropivacaine—Dizziness—Doxorubicin—bone cancer	0.000146	0.000531	CcSEcCtD
Ropivacaine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000143	0.0117	CbGpPWpGaD
Ropivacaine—Nausea—Epirubicin—bone cancer	0.000141	0.000516	CcSEcCtD
Ropivacaine—Vomiting—Doxorubicin—bone cancer	0.00014	0.000511	CcSEcCtD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000139	0.0113	CbGpPWpGaD
Ropivacaine—Rash—Doxorubicin—bone cancer	0.000139	0.000506	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—bone cancer	0.000139	0.000506	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—bone cancer	0.000138	0.000503	CcSEcCtD
Ropivacaine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000137	0.0112	CbGpPWpGaD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—KIT—bone cancer	0.000134	0.0109	CbGpPWpGaD
Ropivacaine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000132	0.0108	CbGpPWpGaD
Ropivacaine—Nausea—Doxorubicin—bone cancer	0.000131	0.000477	CcSEcCtD
Ropivacaine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000127	0.0103	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000118	0.00959	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000114	0.0093	CbGpPWpGaD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	9.3e-05	0.00759	CbGpPWpGaD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	9.17e-05	0.00749	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	9.07e-05	0.0074	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—EGFR—bone cancer	8.88e-05	0.00725	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	8.62e-05	0.00704	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.54e-05	0.00615	CbGpPWpGaD
Ropivacaine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	7.43e-05	0.00607	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—bone cancer	7.18e-05	0.00586	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—bone cancer	6.87e-05	0.00561	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	6.77e-05	0.00553	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MET—bone cancer	6.62e-05	0.00541	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—bone cancer	6.6e-05	0.00539	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—bone cancer	6.6e-05	0.00539	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	6.46e-05	0.00527	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	6.38e-05	0.0052	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—bone cancer	6.36e-05	0.00519	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—bone cancer	6.36e-05	0.00519	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP2—bone cancer	5.53e-05	0.00451	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5.47e-05	0.00447	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	5.4e-05	0.00441	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MET—bone cancer	5.36e-05	0.00437	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	5.24e-05	0.00428	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MET—bone cancer	5.12e-05	0.00418	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MET—bone cancer	4.92e-05	0.00402	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MET—bone cancer	4.92e-05	0.00402	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MET—bone cancer	4.75e-05	0.00387	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MET—bone cancer	4.75e-05	0.00387	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CDK4—bone cancer	4.73e-05	0.00386	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MET—bone cancer	4.73e-05	0.00386	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—bone cancer	4.47e-05	0.00365	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP2—bone cancer	4.47e-05	0.00365	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.44e-05	0.00362	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP2—bone cancer	4.27e-05	0.00349	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP9—bone cancer	4.15e-05	0.00339	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP2—bone cancer	4.11e-05	0.00335	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP2—bone cancer	4.11e-05	0.00335	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	4e-05	0.00327	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP2—bone cancer	3.96e-05	0.00323	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP2—bone cancer	3.96e-05	0.00323	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	3.95e-05	0.00322	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP2—bone cancer	3.94e-05	0.00322	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	3.86e-05	0.00315	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CDK4—bone cancer	3.82e-05	0.00312	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MET—bone cancer	3.82e-05	0.00312	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CDK4—bone cancer	3.66e-05	0.00298	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MET—bone cancer	3.66e-05	0.00298	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	3.65e-05	0.00298	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CDK4—bone cancer	3.51e-05	0.00287	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MET—bone cancer	3.51e-05	0.00287	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MET—bone cancer	3.51e-05	0.00287	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CDK4—bone cancer	3.51e-05	0.00287	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	3.45e-05	0.00281	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—GSTP1—bone cancer	3.42e-05	0.00279	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CDK4—bone cancer	3.39e-05	0.00276	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MET—bone cancer	3.39e-05	0.00276	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MET—bone cancer	3.39e-05	0.00276	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CDK4—bone cancer	3.39e-05	0.00276	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	3.38e-05	0.00276	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP9—bone cancer	3.36e-05	0.00274	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—bone cancer	3.36e-05	0.00274	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MET—bone cancer	3.34e-05	0.00272	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP9—bone cancer	3.21e-05	0.00262	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP2—bone cancer	3.19e-05	0.0026	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	3.11e-05	0.00254	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP9—bone cancer	3.09e-05	0.00252	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP9—bone cancer	3.09e-05	0.00252	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP2—bone cancer	3.05e-05	0.00249	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	3e-05	0.00245	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP9—bone cancer	2.98e-05	0.00243	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP9—bone cancer	2.98e-05	0.00243	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP9—bone cancer	2.96e-05	0.00242	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP2—bone cancer	2.93e-05	0.00239	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP2—bone cancer	2.93e-05	0.00239	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP2—bone cancer	2.83e-05	0.00231	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP2—bone cancer	2.83e-05	0.00231	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	2.81e-05	0.00229	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP2—bone cancer	2.78e-05	0.00227	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	2.78e-05	0.00227	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	2.74e-05	0.00224	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—bone cancer	2.71e-05	0.00222	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	2.7e-05	0.00221	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—bone cancer	2.6e-05	0.00212	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—bone cancer	2.49e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—bone cancer	2.49e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—bone cancer	2.41e-05	0.00196	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—bone cancer	2.41e-05	0.00196	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.4e-05	0.00196	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NDUFA12—bone cancer	2.4e-05	0.00196	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—bone cancer	2.4e-05	0.00196	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—bone cancer	2.39e-05	0.00195	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MET—bone cancer	2.38e-05	0.00194	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CDK4—bone cancer	2.38e-05	0.00194	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—GSTP1—bone cancer	2.38e-05	0.00194	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	2.36e-05	0.00192	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	2.35e-05	0.00192	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	2.32e-05	0.0019	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—bone cancer	2.29e-05	0.00187	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—bone cancer	2.2e-05	0.0018	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—bone cancer	2.2e-05	0.0018	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	2.13e-05	0.00174	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	2.13e-05	0.00174	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—bone cancer	2.12e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—bone cancer	2.12e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—bone cancer	2.09e-05	0.00171	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—GSTP1—bone cancer	2.02e-05	0.00165	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NT5C3A—bone cancer	1.99e-05	0.00162	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.99e-05	0.00162	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—bone cancer	1.99e-05	0.00162	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—bone cancer	1.94e-05	0.00158	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—bone cancer	1.85e-05	0.00151	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—bone cancer	1.78e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—bone cancer	1.78e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—bone cancer	1.72e-05	0.0014	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—bone cancer	1.72e-05	0.0014	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—bone cancer	1.69e-05	0.00138	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NDUFA12—bone cancer	1.67e-05	0.00136	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.56e-05	0.00127	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.53e-05	0.00125	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—bone cancer	1.49e-05	0.00122	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NDUFA12—bone cancer	1.41e-05	0.00115	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NT5C3A—bone cancer	1.38e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—bone cancer	1.21e-05	0.000985	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NT5C3A—bone cancer	1.17e-05	0.000956	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NDUFA12—bone cancer	1.09e-05	0.00089	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NT5C3A—bone cancer	9.04e-06	0.000737	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—bone cancer	8.71e-06	0.000711	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—DHFR—bone cancer	8.08e-06	0.000659	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNA11—bone cancer	7.55e-06	0.000616	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP3A4—bone cancer	6.85e-06	0.000559	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—bone cancer	6.05e-06	0.000494	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GSTP1—bone cancer	5.86e-06	0.000478	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—DHFR—bone cancer	5.62e-06	0.000458	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNA11—bone cancer	5.25e-06	0.000428	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—bone cancer	5.13e-06	0.000419	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP3A4—bone cancer	4.76e-06	0.000388	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—DHFR—bone cancer	4.76e-06	0.000388	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNA11—bone cancer	4.45e-06	0.000363	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GSTP1—bone cancer	4.07e-06	0.000332	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP3A4—bone cancer	4.03e-06	0.000329	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.01e-06	0.000327	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—bone cancer	3.96e-06	0.000323	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—DHFR—bone cancer	3.67e-06	0.0003	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GSTP1—bone cancer	3.45e-06	0.000281	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNA11—bone cancer	3.43e-06	0.00028	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—bone cancer	3.03e-06	0.000248	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GSTP1—bone cancer	2.66e-06	0.000217	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—bone cancer	2.11e-06	0.000172	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—bone cancer	1.79e-06	0.000146	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—bone cancer	1.38e-06	0.000113	CbGpPWpGaD
